APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ultra-low Molecular Weight Heparin (ULMWH)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ultra-low Molecular Weight Heparin (ULMWH) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025197 pages

Choose your research edition.

Industry ResearchUltra-low Molecular Weight Heparin (ULMWH) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Ultra-low Molecular Weight Heparin (ULMWH) Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Ultra-low Molecular Weight Heparin (ULMWH) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ultra-low Molecular Weight Heparin (ULMWH) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ultra-low Molecular Weight Heparin (ULMWH) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Ultra-low Molecular Weight Heparin (ULMWH) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ultra-low Molecular Weight Heparin (ULMWH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ultra-low Molecular Weight Heparin (ULMWH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ultra-low Molecular Weight Heparin (ULMWH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ultra-low Molecular Weight Heparin (ULMWH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ultra-low Molecular Weight Heparin (ULMWH) include Aspen Oss, Bioiberica, Deebio, Dongcheng Biochemicals, Hepalink, King-friend Biochemical Pharmaceutical, Opocrin, Tiandong and Xinbai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ultra-low Molecular Weight Heparin (ULMWH) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ultra-low Molecular Weight Heparin (ULMWH) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ultra-low Molecular Weight Heparin (ULMWH) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ultra-low Molecular Weight Heparin (ULMWH) market size, projected growth trends, production technologies, key applications, and end-use industries.

Ultra-low Molecular Weight Heparin (ULMWH) Segment by Company

Aspen Oss

Bioiberica

Deebio

Dongcheng Biochemicals

Hepalink

King-friend Biochemical Pharmaceutical

Opocrin

Tiandong

Xinbai

Yino Pharma Limited

Changshan Pharm

Qianhong Bio-pharma

Pfizer

Jiulong Biochemicals

Ultra-low Molecular Weight Heparin (ULMWH) Segment by Type

Oral

Parenteral

Ultra-low Molecular Weight Heparin (ULMWH) Segment by Application

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Ultra-low Molecular Weight Heparin (ULMWH) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ultra-low Molecular Weight Heparin (ULMWH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ultra-low Molecular Weight Heparin (ULMWH) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ultra-low Molecular Weight Heparin (ULMWH).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ultra-low Molecular Weight Heparin (ULMWH) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ultra-low Molecular Weight Heparin (ULMWH) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ultra-low Molecular Weight Heparin (ULMWH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ultra-low Molecular Weight Heparin (ULMWH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ultra-low Molecular Weight Heparin (ULMWH) Industry Trends Table 2. Ultra-low Molecular Weight Heparin (ULMWH) Industry Drivers Table 3. Ultra-low Molecular Weight Heparin (ULMWH) Industry Opportunities and Challenges Table 4. Ultra-low Molecular Weight Heparin (ULMWH) Industry Restraints Table 5. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Manufacturers Table 9. Global Ultra-low Molecular Weight Heparin (ULMWH) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Ultra-low Molecular Weight Heparin (ULMWH) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ultra-low Molecular Weight Heparin (ULMWH) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ultra-low Molecular Weight Heparin (ULMWH) Manufacturers, Product Type & Application Table 13. Global Ultra-low Molecular Weight Heparin (ULMWH) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ultra-low Molecular Weight Heparin (ULMWH) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Parenteral Table 18. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Type (2021-2026) & (W Units) Table 20. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Type (2027-2032) & (W Units) Table 21. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Type (2021-2026) Table 22. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Type (2027-2032) Table 23. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Type (2021-2026) & (W Units) Table 25. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Type (2027-2032) & (W Units) Table 26. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Type (2021-2026) Table 27. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Treatment of Venous Thromboembolism Table 29. Major Manufacturers of Complications of Pregnancy Table 30. Major Manufacturers of Cardioversion of Atrial Fibrillation/Flutter Table 31. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Application (2021-2026) & (W Units) Table 33. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Application (2027-2032) & (W Units) Table 34. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Application (2021-2026) Table 35. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Application (2027-2032) Table 36. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Application (2021-2026) & (W Units) Table 38. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Application (2027-2032) & (W Units) Table 39. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Application (2021-2026) Table 40. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Application (2027-2032) Table 41. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Region (2021-2026) & (W Units) Table 43. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Region (2021-2026) Table 44. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2021-2026) & (W Units) Table 48. North America Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2027-2032) & (W Units) Table 49. Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2021-2026) & (W Units) Table 51. Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2027-2032) & (W Units) Table 58. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Region (2021-2026) Table 62. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Region (2027-2032) Table 63. Aspen Oss Company Information Table 64. Aspen Oss Business Overview Table 65. Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 67. Aspen Oss Recent Development Table 68. Bioiberica Company Information Table 69. Bioiberica Business Overview Table 70. Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 72. Bioiberica Recent Development Table 73. Deebio Company Information Table 74. Deebio Business Overview Table 75. Deebio Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Deebio Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 77. Deebio Recent Development Table 78. Dongcheng Biochemicals Company Information Table 79. Dongcheng Biochemicals Business Overview Table 80. Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 82. Dongcheng Biochemicals Recent Development Table 83. Hepalink Company Information Table 84. Hepalink Business Overview Table 85. Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 87. Hepalink Recent Development Table 88. King-friend Biochemical Pharmaceutical Company Information Table 89. King-friend Biochemical Pharmaceutical Business Overview Table 90. King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 92. King-friend Biochemical Pharmaceutical Recent Development Table 93. Opocrin Company Information Table 94. Opocrin Business Overview Table 95. Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 97. Opocrin Recent Development Table 98. Tiandong Company Information Table 99. Tiandong Business Overview Table 100. Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 102. Tiandong Recent Development Table 103. Xinbai Company Information Table 104. Xinbai Business Overview Table 105. Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 107. Xinbai Recent Development Table 108. Yino Pharma Limited Company Information Table 109. Yino Pharma Limited Business Overview Table 110. Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 112. Yino Pharma Limited Recent Development Table 113. Changshan Pharm Company Information Table 114. Changshan Pharm Business Overview Table 115. Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 117. Changshan Pharm Recent Development Table 118. Qianhong Bio-pharma Company Information Table 119. Qianhong Bio-pharma Business Overview Table 120. Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 122. Qianhong Bio-pharma Recent Development Table 123. Pfizer Company Information Table 124. Pfizer Business Overview Table 125. Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 127. Pfizer Recent Development Table 128. Jiulong Biochemicals Company Information Table 129. Jiulong Biochemicals Business Overview Table 130. Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio Table 132. Jiulong Biochemicals Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Ultra-low Molecular Weight Heparin (ULMWH) Distributors List Table 136. Ultra-low Molecular Weight Heparin (ULMWH) Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Ultra-low Molecular Weight Heparin (ULMWH) Product Image Figure 2. Global Ultra-low Molecular Weight Heparin (ULMWH) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2021-2032) & (US$ Million) Figure 4. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales (2021-2032) & (W Units) Figure 5. Global Ultra-low Molecular Weight Heparin (ULMWH) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ultra-low Molecular Weight Heparin (ULMWH) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Parenteral Image Figure 10. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Type (2021-2032) Figure 13. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Type (2021-2032) Figure 16. Treatment of Venous Thromboembolism Image Figure 17. Complications of Pregnancy Image Figure 18. Cardioversion of Atrial Fibrillation/Flutter Image Figure 19. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Application (2021-2032) Figure 22. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Application (2021-2032) Figure 25. North America Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Country (2021-2032) Figure 27. U.S. Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Country (2021-2032) Figure 32. Germany Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Country (2021-2032) Figure 39. China Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Country (2021-2032) Figure 47. Brazil Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Ultra-low Molecular Weight Heparin (ULMWH) Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Ultra-low Molecular Weight Heparin (ULMWH) Revenue (2021-2032) & (US$ Million) Figure 58. North America Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Ultra-low Molecular Weight Heparin (ULMWH) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Ultra-low Molecular Weight Heparin (ULMWH) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Ultra-low Molecular Weight Heparin (ULMWH) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Ultra-low Molecular Weight Heparin (ULMWH) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Parenteral
Applications
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
Companies covered
  • Aspen Oss
  • Bioiberica
  • Deebio
  • Dongcheng Biochemicals
  • Hepalink
  • King-friend Biochemical Pharmaceutical
  • Opocrin
  • Tiandong
  • Xinbai
  • Yino Pharma Limited
  • Changshan Pharm
  • Qianhong Bio-pharma
  • Pfizer
  • Jiulong Biochemicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Dynamics
  1. 2.1 Ultra-low Molecular Weight Heparin (ULMWH) Industry Trends
  2. 2.2 Ultra-low Molecular Weight Heparin (ULMWH) Industry Drivers
  3. 2.3 Ultra-low Molecular Weight Heparin (ULMWH) Industry Opportunities and Challenges
  4. 2.4 Ultra-low Molecular Weight Heparin (ULMWH) Industry Restraints
3 Ultra-low Molecular Weight Heparin (ULMWH) Market by Manufacturers
  1. 3.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ultra-low Molecular Weight Heparin (ULMWH) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ultra-low Molecular Weight Heparin (ULMWH) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ultra-low Molecular Weight Heparin (ULMWH) Manufacturers, Product Type & Application
  7. 3.7 Global Ultra-low Molecular Weight Heparin (ULMWH) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ultra-low Molecular Weight Heparin (ULMWH) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ultra-low Molecular Weight Heparin (ULMWH) Tier 1, Tier 2, and Tier 3
4 Ultra-low Molecular Weight Heparin (ULMWH) Market by Type
  1. 4.1 Ultra-low Molecular Weight Heparin (ULMWH) Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Parenteral
  4. 4.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Type
  5. 4.2.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Type (2021-2032)
  7. 4.2.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Type
  9. 4.3.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Type (2021-2032)
  11. 4.3.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Type (2021-2032)
5 Ultra-low Molecular Weight Heparin (ULMWH) Market by Application
  1. 5.1 Ultra-low Molecular Weight Heparin (ULMWH) Application Introduction
  2. 5.1.1 Treatment of Venous Thromboembolism
  3. 5.1.2 Complications of Pregnancy
  4. 5.1.3 Cardioversion of Atrial Fibrillation/Flutter
  5. 5.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Application
  6. 5.2.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Application (2021-2032)
  8. 5.2.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Application
  10. 5.3.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Application (2021-2032)
  12. 5.3.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Application (2021-2032)
6 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Region
  1. 6.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Region (2021-2032)
  3. 6.2.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Region (2021-2026)
  4. 6.2.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region
  1. 7.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region
  2. 7.1.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region (2021-2026)
  4. 7.1.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region (2027-2032)
  5. 7.1.4 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ultra-low Molecular Weight Heparin (ULMWH) Revenue (2021-2032)
  8. 7.2.2 North America Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ultra-low Molecular Weight Heparin (ULMWH) Revenue (2021-2032)
  11. 7.3.2 Europe Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ultra-low Molecular Weight Heparin (ULMWH) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aspen Oss
  2. 8.1.1 Aspen Oss Company Information
  3. 8.1.2 Aspen Oss Business Overview
  4. 8.1.3 Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  6. 8.1.5 Aspen Oss Recent Developments
  7. 8.2 Bioiberica
  8. 8.2.1 Bioiberica Company Information
  9. 8.2.2 Bioiberica Business Overview
  10. 8.2.3 Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  12. 8.2.5 Bioiberica Recent Developments
  13. 8.3 Deebio
  14. 8.3.1 Deebio Company Information
  15. 8.3.2 Deebio Business Overview
  16. 8.3.3 Deebio Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Deebio Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  18. 8.3.5 Deebio Recent Developments
  19. 8.4 Dongcheng Biochemicals
  20. 8.4.1 Dongcheng Biochemicals Company Information
  21. 8.4.2 Dongcheng Biochemicals Business Overview
  22. 8.4.3 Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  24. 8.4.5 Dongcheng Biochemicals Recent Developments
  25. 8.5 Hepalink
  26. 8.5.1 Hepalink Company Information
  27. 8.5.2 Hepalink Business Overview
  28. 8.5.3 Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  30. 8.5.5 Hepalink Recent Developments
  31. 8.6 King-friend Biochemical Pharmaceutical
  32. 8.6.1 King-friend Biochemical Pharmaceutical Company Information
  33. 8.6.2 King-friend Biochemical Pharmaceutical Business Overview
  34. 8.6.3 King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  36. 8.6.5 King-friend Biochemical Pharmaceutical Recent Developments
  37. 8.7 Opocrin
  38. 8.7.1 Opocrin Company Information
  39. 8.7.2 Opocrin Business Overview
  40. 8.7.3 Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  42. 8.7.5 Opocrin Recent Developments
  43. 8.8 Tiandong
  44. 8.8.1 Tiandong Company Information
  45. 8.8.2 Tiandong Business Overview
  46. 8.8.3 Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  48. 8.8.5 Tiandong Recent Developments
  49. 8.9 Xinbai
  50. 8.9.1 Xinbai Company Information
  51. 8.9.2 Xinbai Business Overview
  52. 8.9.3 Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  54. 8.9.5 Xinbai Recent Developments
  55. 8.10 Yino Pharma Limited
  56. 8.10.1 Yino Pharma Limited Company Information
  57. 8.10.2 Yino Pharma Limited Business Overview
  58. 8.10.3 Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  60. 8.10.5 Yino Pharma Limited Recent Developments
  61. 8.11 Changshan Pharm
  62. 8.11.1 Changshan Pharm Company Information
  63. 8.11.2 Changshan Pharm Business Overview
  64. 8.11.3 Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  66. 8.11.5 Changshan Pharm Recent Developments
  67. 8.12 Qianhong Bio-pharma
  68. 8.12.1 Qianhong Bio-pharma Company Information
  69. 8.12.2 Qianhong Bio-pharma Business Overview
  70. 8.12.3 Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  72. 8.12.5 Qianhong Bio-pharma Recent Developments
  73. 8.13 Pfizer
  74. 8.13.1 Pfizer Company Information
  75. 8.13.2 Pfizer Business Overview
  76. 8.13.3 Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  78. 8.13.5 Pfizer Recent Developments
  79. 8.14 Jiulong Biochemicals
  80. 8.14.1 Jiulong Biochemicals Company Information
  81. 8.14.2 Jiulong Biochemicals Business Overview
  82. 8.14.3 Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio
  84. 8.14.5 Jiulong Biochemicals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ultra-low Molecular Weight Heparin (ULMWH) Value Chain Analysis
  2. 9.1.1 Ultra-low Molecular Weight Heparin (ULMWH) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ultra-low Molecular Weight Heparin (ULMWH) Production Mode & Process
  6. 9.2 Ultra-low Molecular Weight Heparin (ULMWH) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ultra-low Molecular Weight Heparin (ULMWH) Distributors
  9. 9.2.3 Ultra-low Molecular Weight Heparin (ULMWH) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst